MARTIN R. HIGGS, PhD
Research group focuses on cellular response to DNA damage and lysine methylation in cancer development and therapy response.
Dr. Karthikkumar Venkatachalam
Olga Glazova, PhD
Life sciences professional with 12+ years in molecular biology and genome engineering. Experienced in driving complex multitasking long-term RnD projects, stakeholder communication, and building reliable lab workflows.
Dr. Richard Jayaraj
Neuroscientist with over 15 years of international research experience across four countries, specializing in multi-disciplinary pre-clinical and clinical projects spanning in silico, in vitro, and in vivo disease models and human biomarkers. I started my research journey from a humble background, without access to sophisticated labs or resources, yet went on to complete my PhD […]
Catalina Vasilescu, PhD
Translational scientist, with more than 14 years of experience in mitochondrial biology, rare genetic disease, genomic medicine, and oligonucleotide therapeutics. Co-author on more than 13 peer-reviewed publications including JACC, Communication Biology, Nature, and Nature Genetics. Medix Prize for Clinical Research 2019. Consulting services: Antisense oligonucleotide and splice-correction programs: ASO design and tiling, cell-based screening cascades, […]
Sudipta Dutta
A growth-oriented researcher with over 10 years of experience in endocrinology, cell and molecular biology, in vivo studies. Ability to learn new techniques; experienced in data analysis, data interpretation, data management, and solving complex problems. Strong oral and written communication skills, cross-functional team collaboration and ability to present scientific data and concepts as evidenced by […]
Gwang Jin (Josephus) Kim
Senior Data Scientist computational biologist PhD Molecular Medicine with long-term experience delivering end-to-end analytics across disease research and Pharma Biotech environments from multi-omics single-cell bulk RNA-seq ChIP/ATAC to applied ML CNNs sequence models and robust reproducible pipelines. Clinical-facing background from a university hospital setting Freiburg Germany worked with patient-derived cohort data under ethics approval informed […]
MEHDI SOLEYMANI-GOLOUJEH, Ph.D.
Postdoctoral scientist with 2+ years of post-PhD experience designing and characterizing engineered human pluripotent stem cell lines at the UCSF Diabetes Center. Applies CRISPR/Cas9-based genome engineering, HDR-oriented knock-in/knockout strategies, TALEN-related workflows, and lentiviral effector systems to build hPSC-derived models of inflammation-driven cell death, with multi-lineage differentiation experience relevant to neural and microglial lineage workflows used […]
Jeffrey M. Skredenske
Accomplished expert in biologics (upstream and downstream) and bioconjugation with deep experience in process development, manufacturing, and process validation. Demonstrated success leading cross-functional teams and managing strategic CDMO partnerships to advance monoclonal antibody and antibody-drug conjugate programs through early- and late-phase clinical trials and IND and BLA preparation and submission. Strong background in high-impact project […]
Yasmeen Mohamed Attia, PhD
I am a Professor of Pharmacology and Toxicology at the Faculty of Pharmacy, The British University in Egypt, a Fulbright Visiting Scholar, Postgraduate Programme Director and Leader of the Drug Research and Development Group (DRD-G) at the Health Research Center of Excellence. My expertise spans translational experimental research, cancer pharmacology, immune-metabolic regulation, drug response modelling […]